Shares of Danaher Corp. DHR inched 0.38% higher to $239.10 Tuesday, on what proved to be an all-around dismal trading session ...

Discover why Danaher is a strong investment choice with its wide moat business model, M&A strategy, and growth potential for ...

CWA Asset Management Group LLC reduced its position in shares of Danaher Co. (NYSE:DHR – Free Report) by 13.1% during the 4th ...

Danaher (NYSE:DHR – Get Free Report) had its price objective cut by analysts at Citigroup from $305.00 to $285.00 in a note ...

In a report released on January 2, Patrick B Donnelly from Citi maintained a Buy rating on Danaher (DHR – Research Report), with a price target ...

We recently compiled a list of the 8 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where ...

Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on ...

A line-up of experts across academia, pharma, and healthcare came together to discuss the impact and challenges of ...

Danaher Corp (DHR) stock saw a modest uptick, ending the day at $229.81 which represents a slight increase of $0.26 or 0.11% from the prior close of $229.55. The stock opened at $230.72 and touched a ...

On Tuesday, Danaher Corp (DHR) stock saw a decline, ending the day at $229.55 which represents a decrease of $-0.10 or -0.04% from the prior close of $229.65. The stock opened at $ and touched a low ...

The stock's rise snapped a three-day losing streak.